stocktrader

General Motors earnings: here’s an $11.5B reason to buy GM stock

General Motors (GM) shares are inching higher on Tuesday morning after the automaker posted a powerhouse Q2 earnings release, outperforming Street expectations across key operational metrics Revenue came in just over $48 billion – reflecting a 1.9% year-over-year increase – while adjusted earnings per share went up 41.3% versus last year to $3.57 in the… Continue reading General Motors earnings: here’s an $11.5B reason to buy GM stock

SCHD just hit a crucial milestone: is it a good dividend ETF to buy?

The Schwab US Dividend Equity ETF (SCHD) has reached a major milestone this year, driven by robust investor inflows and solid market performance. The fund recently surpassed $100 billion in assets under management (AUM), making it the second-largest dividend ETF behind the Vanguard Dividend Appreciation ETF (VIG). With SCHD hitting this landmark, is it still… Continue reading SCHD just hit a crucial milestone: is it a good dividend ETF to buy?

Why are Adobe and Workday stocks falling today?

Adobe ADBE shares fell sharply in trading on Tuesday after Morgan Stanley downgraded the creative software maker, warning that multiple strategic transitions are unfolding simultaneously and could complicate its ability to return to stronger growth. The investment bank lowered its rating on Adobe from Equal-weight to Underweight and slashed its price target by more than… Continue reading Why are Adobe and Workday stocks falling today?

Dow jumps 230 points as chip stocks rebound ahead of Big Tech earnings

US stocks opened higher on Tuesday, led by a rebound in semiconductor stocks, as investors shifted their focus toward upcoming Big Tech earnings while continuing to monitor developments in the conflict between the United States and Iran. The Dow Jones Industrial Average gained 234 points, or 0.45%, while the S&P 500 advanced 0.58%. The Nasdaq… Continue reading Dow jumps 230 points as chip stocks rebound ahead of Big Tech earnings

From dilution to cash flow: Is BitMine stock worth buying now?

BitMine’s stock price has rebounded over the past few days, hovering near its highest level in more than a month. BMNR has surged 32% from its year-to-date low, with the recovery gaining momentum as investors anticipate the company’s transition from a cash-burning business into a potential free cash flow machine. BitMine has continued to accumulate… Continue reading From dilution to cash flow: Is BitMine stock worth buying now?

Celestica stock tumbles ahead of earnings: rebound or more pain?

Celestica stock has moved into a bear market, mirroring the performance of other artificial intelligence (AI) companies. CLS dropped to $307 in New York, down by over 35% from its highest level this year. This retreat will be put to the test when the company publishes its financial results next week. Celestica stock in focus… Continue reading Celestica stock tumbles ahead of earnings: rebound or more pain?

Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

Novo Nordisk has filed a lawsuit against Eli Lilly (LLY) in a US federal court, accusing its rival of running false and misleading advertising campaigns for its blockbuster diabetes and weight-loss drugs. The lawsuit, filed Tuesday in the US District Court for the District of New Jersey, alleges that Eli Lilly and Lilly USA violated… Continue reading Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

AMD stock jumps 4%: is Microsoft’s AI deal just the opening act?

AMD stock jumped more than 4% in premarket trading on Tuesday as Microsoft’s endorsement of its artificial-intelligence platform fuelled expectations that a broader customer push could follow. The stock had already gained 5.1% on Monday after Microsoft said it would deploy AMD’s Helios rack-scale systems and next-generation EPYC processors across Azure. The agreement gives AMD… Continue reading AMD stock jumps 4%: is Microsoft’s AI deal just the opening act?